AI MARKET SCANNING

ACADIA Pharmaceuticals Inc.

🏛️ NASDAQ 📁 Healthcare 🏭 Biotechnology
AVG HISTORICAL GAP -0.96%
MAX GAP RECORD -18.30%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $ACAD
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Aug 04, 2026 Earnings Release 2026-08-04 (AFTER CLOSE)
+2.98%
May 06, 2026 Earnings Release 2026-05-06 (AFTER CLOSE)
+1.91%
Feb 25, 2026 Earnings Release 2026-02-25 (AFTER CLOSE)
-5.33%
Nov 05, 2025 Earnings Release 2025-11-05 (AFTER CLOSE)
+5.60%
Aug 06, 2025 Earnings Release 2025-08-06 (AFTER CLOSE)
+1.09%
May 07, 2025 Earnings Release 2025-05-07 (AFTER CLOSE)
-0.61%
Feb 26, 2025 Earnings Release 2025-02-26 (AFTER CLOSE)
+2.32%
Nov 06, 2024 Earnings Release 2024-11-06 (AFTER CLOSE)
-0.63%

VOLATILITY & GAP BIAS

AVG GAP MOVE 3.9%
Bullish Gaps (8)
Bearish Gaps (4)
Neutral / Flat (3)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $ACAD

EXECUTIONS1 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
2026-08-05 🔒 PRO RADAR ••• x• $•••.•• → $•••.•• 1242m +48.60%
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for neurological and rare disease in North America. The company offers NUPLAZID (pimavanserin), a selective serotonin inverse agonist/antagonist for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis; and DAYBUE, a novel synthetic analog…

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗